Molecular imaging of hypoxia

Area of Science:

• Oncology
• Nuclear Medicine
• Medical Imaging

Background:

• Tumor oxygenation and hypoxia are critical factors in cancer progression and treatment response.
• Various imaging techniques have been developed to monitor these parameters in vivo.
• Nuclear medicine, utilizing radiolabeled hypoxia markers, is a leading approach for hypoxia imaging.

Purpose of the Study:

• To review the advancements in imaging approaches for monitoring tumor oxygenation and hypoxia.
• To highlight the role of nuclear medicine in hypoxia imaging.
• To discuss the clinical applications of hypoxia imaging in individualizing cancer therapy.

Main Methods:

• Review of existing literature on hypoxia imaging techniques.
• Focus on radiolabeled tracers used in nuclear medicine for hypoxia detection.
• Analysis of clinical progression from detection to therapeutic individualization.

Main Results:

• Nuclear medicine has developed effective radiolabeled hypoxia markers.
• Hypoxia imaging is increasingly adopted in clinical settings.
• The application of hypoxia imaging is expanding beyond detection to treatment personalization.

Conclusions:

• Nuclear medicine provides a preferred method for in vivo tumor hypoxia imaging.
• Hypoxia imaging is transitioning into a key tool for tailoring chemoradiotherapy.
• Further integration of hypoxia imaging promises improved cancer treatment strategies.